[1-(4-环己基脲基苯氧基)-2-羟基-3-叔丁氨基丙烷（他林洛尔，Cordanum，02-115）的药代动力学 2. 大鼠体内14C标记化合物的排泄、血药浓度及分布] - Suppr | 超能文献

[The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].

作者信息

Klemm W, Wenzel A

出版信息

Pharmazie. 1975 Oct;30(10):675-7.

PMID:695

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].[1-(4-环己基脲基苯氧基)-2-羟基-3-叔丁氨基丙烷（他林洛尔，Cordanum，02-115）的药代动力学 2. 大鼠体内14C标记化合物的排泄、血药浓度及分布]

Pharmazie. 1975 Oct;30(10):675-7.

2

[The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115). 1. Blood levels in dogs].[1-(4-环己基脲基苯氧基)-2-羟基-3-叔丁氨基丙烷（他林洛尔，可坦，02-115）的药代动力学。1. 犬的血药浓度]

Pharmazie. 1975 Oct;30(10):673-5.

3

[Study on the chronic toxicity of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane(talinolol, Cordanum, 02-115) in the rat and the beagle].1-(4-环己基脲基苯氧基)-2-羟基-3-叔丁胺基丙烷（他林洛尔，科达隆，02-115）对大鼠和比格犬的慢性毒性研究

Pharmazie. 1975 Oct;30(10):659-68.

4

[The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].[1-(4-环己基脲基苯氧基)-2-羟基-3-叔丁氨基丙烷（他林洛尔，科达隆，02-115）、普拉洛尔和普萘洛尔对大鼠血清脂质含量的影响]

Pharmazie. 1975 Oct;30(10):656-8.

5

On the pharmacokinetics of talinolol, a new beta 1-receptor blocking agent.关于新型β1受体阻滞剂他林洛尔的药代动力学

Int J Clin Pharmacol Ther Toxicol. 1981 Sep;19(9):392-5.

6

[Quantitative colorimetric determination of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert butylaminopropane (talinolol Cordanum, 02-115) in body fluids].[体液中1-(4-环己基脲基苯氧基)-2-羟基-3-叔丁氨基丙烷（他林洛尔，科达隆，02-115）的定量比色测定]

Pharmazie. 1975 Oct;30(10):673.

7

Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.大鼠单次给药后[14C]依巴斯汀的吸收、分布、代谢和排泄

Arzneimittelforschung. 1994 Apr;44(4):527-38.

8

Metabolic studies in patients with nadolol: oral and intravenous administration.纳多洛尔患者的代谢研究：口服与静脉给药

J Clin Pharmacol. 1977 May-Jun;17(5-6):300-7. doi: 10.1002/j.1552-4604.1977.tb04609.x.

9

Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).一种新型β-肾上腺素能阻滞剂1-叔丁基氨基-3-（1,2,3,4-四氢-1,4-亚乙基-8-羟基-5-萘氧基）-2-丙醇（K 5407）的药代动力学和代谢

Eur J Drug Metab Pharmacokinet. 1980;5(1):9-20. doi: 10.1007/BF03189437.

10

Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 2nd communication: A single oral administration of [14C]nipradilol to spontaneously hypertensive rats.新型抗高血压药物尼普地洛在大鼠体内的药代动力学。第二篇通讯：对自发性高血压大鼠单次口服[14C]尼普地洛。

Arzneimittelforschung. 1985;35(11):1680-4.